CClinicalTrials.gg
CompletedNCT02742220Updated Feb 5, 2018

Isometric Handgrip Training on Blood Pressure of Peripheral Artery Disease Patients

An interventional study of Isometric Handgrip Training Group and Control Group in Peripheral Artery Disease, sponsored by University of Pernambuco. Completed at 1 site in Brazil. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2018-02-05.

Sponsored by University of Pernambuco · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

The aim of this study is to analyze the effects of isometric handgrip training (IHT) on blood pressure of hypertensive patients with peripheral arterial disease. Will be recruited 60 patients which will be randomized into 2 groups (30 per group), IHT and control group (CG). IHT group will training isometric contraction for 8 weeks. The GC patients will be encouraged to increase the level of physical activity. In the pre and post-intervention, brachial and central blood pressure will be measured.

Read the detailed description

Meta-analyze studies have shown that IHT promotes reductions in blood pressure (BP), reaching 10 mmHg for systolic and diastolic 7 mmHg. However, remain uncertain the effects of this type of training on BP in patients with more severe cardiovascular diseases such as peripheral artery disease. Because this type of training which requires approximately 20 minutes per session and does not require supervision, it is possible that this intervention is interesting to reduce BP of these patients. The aim of this study is to analyze the effects of IHT on blood pressure of hypertensive patients with peripheral arterial disease. Will be recruited 60 patients, which will be randomized into 2 groups (30 per group), IHT and control group (CG). IHT group will hold three sessions per week with four unilateral sets with two minutes of isometric contraction at 30% of maximal voluntary contraction and interval of four minutes between them, for 8 weeks. The GC patients will be encouraged to increase the level of physical activity. In the pre and post-intervention, is going to be evaluated functional capacity, brachial and central BP, arterial stiffness, cardiovascular autonomic modulation and muscle vasodilation. Will be used to analyze two-factor variance for repeated measures, with group (IHT and GC) and the time (before and after 8 weeks) as factors and the post-hoc test of Newman-Keuls.

02

Conditions studied

  • Peripheral Artery Disease

Keywords

  • intermittent claudication
  • exercise
  • blood pressure
  • cardiovascular system
03

In context

Peripheral Arterial Disease

1,542 studies on the registry are indexed under Peripheral Arterial Disease; 282 are open to participants now.

This study's enrollment of 102 is above the median of 74 across 1,066 interventional studies indexed under Peripheral Arterial Disease.

Browse Peripheral Arterial Disease studies →

Lead sponsor

University of Pernambuco is the lead sponsor of 27 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • postmenopausal without hormone therapy replacement, if woman;
  • present peripheral artery disease (ankle brachial index \< 0.90) in one or both lower limbs;
  • do not present neurological / cognitive diseases;
  • is able to practice home-based exercise;

Exclusion criteria

Exclusion Criteria:

  • patients will only be excluded if they make any medication changes before completing the intervention period or present any health problems that prevent physical activity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
102 participants (actual)

Study arms

  • Experimental
    Isometric Handgrip Training Group

    Experimental group will perform home-based unilateral handgrip exercise and will be recommended to increase daily physical activity levels.

    Other: Isometric Handgrip Training Group

  • Sham comparator
    Control Group

    Control group will be recommended to increase daily physical activity levels.

    Other: Control Group

Interventions

  • OtherIsometric Handgrip Training Group

    Intervention period will last eight weeks. Experimental group will perform three sessions per week of home-based handgrip exercise. The exercise protocol will consist of four unilateral sets (dominant arm) with two minutes of isometric contraction, with 30% of maximum voluntary contraction, and four minutes of interval between sets. Patients will receive a diary to record the sessions and report difficulties during the training. Visits will be scheduled at weeks 1 and 5 to provide feedback to individuals, discuss possible problems during the training and adjust the intensity of the exercise. In addition the patients be recommended to increase daily physical activity levels, and weekly, there will be phone contacts with the patients to reinforce the exercise recommendations.

    Also known as: Isometric resistance exercise

  • OtherControl Group

    Intervention period will last eight weeks. Patients will be recommended to increase daily physical activity levels, and weekly, there will be phone contacts to reinforce the recommendations.

06

What researchers measure

Primary outcomes

  1. Change from baseline in blood pressure at eight weeks

    Blood pressure will be measured before and after eight weeks of intervention period on intervention and control group by an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan).

    Time frame: Baseline and eight weeks

Secondary outcomes

  1. Change from baseline in autonomic cardiac modulation at eight weeks

    Cardiac autonomic modulation will be measured before and after eight weeks of intervention period on intervention and control group by heart rate monitor (Polar, RS 800, USA).

    Time frame: Baseline and eight weeks

  2. Change from baseline in vasodilatory capacity at eight weeks

    Vasodilatory capacity will be measured before and after eight weeks of intervention period on intervention and control group by a flow mediated dilation measurement with an ultrasound image (HDI 5000 Sono CT, Philips, The Netherlands).

    Time frame: Baseline and eight weeks

  3. Change from baseline in arterial stiffness at eight weeks

    Arterial stiffness will be measured before and after eight weeks of intervention period on intervention and control group by pulse wave velocity measurement with applanation tonometry (SphygmoCor, AtCor Medical, Australia).

    Time frame: Baseline and eight weeks

07

Study locations

1 site
  • Israel Institute of Education and Research Albert Einstein
    São Paulo, 05652-900, Brazil
08

References and documents

Publications

  • A Correia M, Oliveira PL, Farah BQ, Vianna LC, Wolosker N, Puech-Leao P, Green DJ, Cucato GG, Ritti-Dias RM. Effects of Isometric Handgrip Training in Patients With Peripheral Artery Disease: A Randomized Controlled Trial. J Am Heart Assoc. 2020 Feb 18;9(4):e013596. doi: 10.1161/JAHA.119.013596. Epub 2020 Feb 6. PubMed 32067595 ↗

Individual participant data

Plan to share: Undecided — The IPD data to be shared are the indivividual and mean data of blood pressure responses to eight weeks of isometric handgrip training.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02742220
Lead sponsor
University of Pernambuco
Collaborators
Fundação de Amparo à Pesquisa do Estado de São Paulo
Responsible party
Raphael M. Ritti Dias (PhD, University of Pernambuco) — Principal investigator
First posted
Apr 18, 2016
Start date
Mar 2016
Primary completion
Dec 2017
Completion
Dec 2017
Last update
Feb 5, 2018

Study contacts

Raphael Ritti-Dias, PhD
principal investigator · Israel Institute of Education and Research Albert Einstein
Gabriel Cucato, PhD
study director · Israel Institute of Education and Research Albert Einstein

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion